This invention relates to a tip which is configured to be removably coupled to a laser porator, to facilitating poration of biological tissue, in particular the skin.
Document WO 03/047449 A1 discloses a tip which is configured to be removably coupled to a laser porator. The purpose of this tip is to protect the laser porator from contamination by debris. The debris may result when the laser porator emits a laser pulse onto the skin. The disadvantage of the laser porator as well as the tip disclosed is that they are only suitable for a single shot or single pulse laser system which is able to create a single ablation area on the skin. It is therefore not possible to create a plurality of pores in a single application of the laser porator. Further it is also not possible to reproduce the shape of create pores.
Numerous diseases and conditions involve skin in a direct or indirect manner, and most of the diseases and conditions are associated with or caused by an immunologic response to an exogenous stimulus. While an immunologic response is generally desirable in most instances (e.g., to combat infection), an auto- or alloimmune response is typically detrimental (e.g., in skin transplantation). Treatment of many skin diseases and conditions is often local and topical in response to an etiologic agent or stimulus (e.g., injury or infection). However, various other skin diseases and conditions are more diffuse in presentation and may be the result of regional agents or stimuli (e.g., exposure to allergen, radiation, etc.) and may in some cases even have systemic underlying conditions (e.g., histoincompatibility).
While topical treatment is often relatively simple and effective in many cases, treatment of diseases and conditions that manifest themselves in a relatively large area or have a systemic component is significantly more difficult. Conceptually the following option is available.
First, a drug may be applied over a relatively large-area (e.g., by application of topical ointment), but efficacy is often undesirable as the skin presents a permeability barrier to most compounds with molecular weight greater 500 Dalton. Even when the drug is a relatively small molecule, hydrophilic drugs will typically not be effectively delivered. Several strategies have been developed to circumvent at least some of these problems, including chemical approaches (e.g., micro/nanovesicle delivery via encapsulation into liposome and other lipophilic carriers; penetration enhancers, such as azone, alphahydroxy acids, etc) and mechanical approaches (e.g., partial removal of stratum corneum by tape stripping, dermabrasion, etc.). Unfortunately, most mechanical approaches are problematic or impractical, especially when a large area is to be treated, and many chemical approaches are not always well tolerated or difficult to formulate. Moreover, topically delivered dosages are often not high enough to achieve a desired effect.
Some attempts have also been made to improve transdermal delivery of higher volumes of a drug using a laser for puncturing the skin of a patient in a manner that does not result in bleeding. Such perforation typically penetrates through the stratum corneum or both the stratum corneum and the epidermis. This allows drug delivery through the skin. An example of such a laser, described in document EP 1133953 A1, provides one slit-shaped perforation with a width of up to 0.5 mm and a length of up to 2.5 mm. Unfortunately, the rate of drug delivery through such a perforation is limited. This perforation also provokes undesirable skin reactions and the perforation of the skin frequently causes pain. The perforation requires subsequent patch drug application. However, such administration of drugs often results in inconsistent drug dosages, inconvenient usage, and sometimes even in infections.
Therefore, while numerous methods of the administration of a drug into the skin or methods of the administration of a drug through the skin into the blood circulation of the human body are known in the art, all or almost all of them suffer from one or more disadvantages. In addition, while numerous methods for the administration of drugs through biological tissue, in particular through the skin are known in the art, all or almost all of them suffer from one or more disadvantages. Consequently, there is still a need to provide improved apparatuses, compositions and methods to improve drug delivery to the skin, the biological tissue and the human body for treatment of skin related conditions and for the treatment of various diseases and conditions.
The inventors have now discovered that drugs can be safely and effectively applied to biological tissue, in particular an area of skin, in relatively high concentrations by creating a plurality of micropores with in particular predetermined geometry. More preferably, the pores will have a depth that is sufficient to create a channel in the stratum corneum of the skin to allow delivery of a drug to the epidermis, and more preferably to the epidermis and the dermis.
The object of the present invention is to improve the quality of the plurality of micropores created by a laser emitting device.
This problem is solved by a tip configured to be removably coupled to a laser porator and comprising the features of claim 1. Claims 2 to 22 disclose further advantageous tips. The problem is further solved with a laser porator comprising the features of claim 23. Claims 24 to 28 disclose further advantageous laser porators. The problem is further solved by a kit comprising a laser emitting device and a tip and comprising the features of claim 29.
The problem is in particular solved with a tip comprising a first portion that is configured to be removably coupled to a laser porator and a second portion that comprises a tissue biasing element that is configured to deform at least a portion of the tissue such as for example the skin that is within the opening of the tip, and that is subject to a laser treatment.
One advantage of the tip according to the invention is that it guarantees reproducible irradiation intensity on the tissue. A tip as known in the state of art would, if pressure is applied to the device and the tip laying on the tissue, cause the skin to camber into direction of the laser source, causing variable intensity of the laser beam hitting the tissue. This would lead to irreproducible pores, for example because the focal range of the laser is not in the area where the tissue is located, leading to the effect that some pores are not produced and/or some pores are produced with a not reproducible shape. This effect is avoided with the tip according to the invention.
The laser emitting device, also called laser porator, comprises a tip, preferably a disposable tip, through which the laser beam is projected onto the biological tissue such as for example the skin. The tip according to the invention includes a tissue biasing element that, upon contact with the tip, will force the tissue to be treated into a predetermined geometry, so the tissue below the tissue biasing element has a determined geometry.
Most typically, the predetermined geometry will ensure that the average distance between a laser mirror that steers the beam over the skin and the skin that is to be treated is substantially the same. Viewed from another perspective, the tissue biasing element will deform the skin such that the skin that is to be treated will be at the focal point of the laser beam throughout the area that is to be treated. The skin or other biological tissue will therefore be in a predetermined position with respect to the impacting laser beam. Such tissue biasing will allow for consistent application of a laser beam with known and/or uniform parameters onto the biological tissue.
Most preferably, the majority of micropores is dimensioned such that the pores allow administration of a drug to within the human body. To avoid bleeding the micropores are arranged such that the pores do not intersect with a (capillary) blood vessel. With respect to further micropore geometry, it should be appreciated that the side walls of micropores according to the inventive subject matter need not necessarily be straight. Indeed, it should be especially recognized that geometry of the wall of the micropores will have a significant influence on at least two factors that are critical for drug delivery: Among other things, the total inner surface can be easily modified by increasing the pore diameter and/or pore depth. Additionally, or alternatively, the wall angle may also deviate from a right angle (relative to the average surface of the stratum corneum), and as such will lead to an increase of total inner pore surface, and with that an increase in the potential area of drug delivery. Still further increases can be achieved by stepping the side walls of a pore. Second, as the micropores are subject to a healing/natural skin renewal process, the micropore geometry will also determine the time available for delivery of a drug across the micropore walls. Preferably, micropores generated with a porator as described below will not give rise to scarring, possibly due to photoablation and/or relatively small size of the pores.
It is further especially preferred that the laser of a laser porator is operated during pore formation in a q-switched or short pulsed mode and with pulse widths and energies such that laser irradiation will result in a blow-off effect without leading to coagulation. Thus, photoablation and/or photodisruption is particularly preferred. Such irradiation will typically vaporize the tissue with negligible creation of thermal damage. For example, suitable ranges of irradiance will be at least 104 W/cm2, and more preferably at least 105 W/cm2, even more preferably between 105 W/cm2 and 109 W/cm2, and most preferably between 105 W/cm2 and 1012 W/cm2 where energy doses of between about 0.01 J/cm2 to 1000 J/cm2, and more typically 0.1 J/cm2 to 100 J/cm2 are employed. Consequently, the laser pulse width/tissue exposure time is preferably less than 1 ms, more preferably less than 100 μs, even more preferably between 100 μs and 10 ns, and most preferably between 100 μs and 0.1 ps. Sizing and operation of lasers to achieve such parameters is well understood in the art, and many of the lasers and control systems therefore are commercially available. Consequently, and viewed from another perspective, it should be recognized that especially suitable operational parameters will be selected to provide a balance between minimum tissue damage and maximum desired effect.
The tip according to the invention allows the laser beam or the laser pulse to reproducible irradiate the tissue, in particular with reproducible intensity. This allows creating pores with high sophisticated properties. For example it may also be desirable to at least partially coagulate the pore walls A, and most typically the pore bottom 3e as exemplarily depicted in the left pore 2 in
In a further aspect of the inventive subject matter, it is desirable to create a plurality of pores 2 as disclosed in
Thus, multiple applications of a drug through micropores in the same area are realized while maintaining a cosmetically and physiologically desirable environment. As applications as presented herein maintain adjacent tissue viability and structure, contemplated methods are also suitable for administration of a drug in large areas. It should further be especially appreciated that using contemplated methods, compositions, and devices will allow delivery of a high amount of a drug into a patient. Moreover, due to the control over drug delivery kinetic and dynamic via control of the pore geometry, drugs delivery can be personalized to accommodate different skin locations in a patient as well as different skin types among different patients. Similarly, drug delivery kinetic and dynamic can be tailored to a specific drug (e.g., slow delivery for fast acting drug, fast and high quantity delivery for instable drugs, etc.). Especially preferred porators suitable for the tips according to the invention, exemplary methods, and configurations are provided in the applicants' copending patent applications with the following serial numbers, all of which are incorporated by reference herein:
A micro-porator for porating a biological membrane to create a poration may be designed, for example, as the laser micro-porator disclosed in PCT patent application No. PCT/EP2006/061639 of the same applicant, and entitled “Laser microporator and method for operating a laser microporator”.
The biological membrane may be porated according to a method, for example, as disclosed in PCT patent application No. PCT/EP2005/051703 of the same applicant, and entitled “Method for creating a permeation surface”.
A micro-porator for porating a biological membrane and an integrated permeant administering system may be designed, for example, as the microporator disclosed in PCT patent application No. PCT/EP2005/051702 of the same applicant, and entitled “Microporator for porating a biological membrane and integrated permeant administering system”.
A system for transmembrane administration of a permeant and a method for administering a permeant may be designed, for example, as the system disclosed in PCT patent application No. PCT/EP2006/050574 of the same applicant, and entitled “A system for transmembrane administration of a permeant and method for administering a permeant”.
A transdermal delivery system for administration of a drug and a method for administering the drug may be designed, for example, as the system disclosed in PCT patent application No. PCT/EP2006/067159 of the same applicant, and entitled “Transdermal delivery system and method for treating infertility”.
Thus, in one preferred aspect, the inventors contemplate a tip and a laser porator for porating a biological tissue such as the skin, for example for treating a skin related disease or disorder in which an area of porated skin is formed and wherein the area comprises a plurality of pores. Most typically, the area is equal or greater than 1 cm2, more typically equal or greater than 10 cm2, even more typically equal or greater than 25 cm2 or greater than 100 cm2. The number of pores may vary considerably, and suitable numbers include those in the range of between about 10-100,000. However, and especially where large areas are treated, higher numbers are also contemplated. Therefore, the number of pores/cm2 may generally vary between about 1-10, more typically 10-100, or 100-1000, and in rare cases even higher. Similarly, the pattern of pores in the skin may vary as well, and isotropic distribution is generally preferred. However, and especially where anatomically and/or physiologically advisable, anisotropic distribution is also contemplated. For example, areas of relatively slow drug diffusion (e.g., fibrotic tissue, thick epidermis, thick stratum corneum, etc.) may have a higher number of pores, whereas other areas may have less. Similarly, areas with disease focus may concentrate the pores in the focus and reduce the number of pores in the periphery. Similarly, areas that require a high dosage or volume of the drug may have a higher density in pores than those that require a lower dosage. In another preferred aspect, the inventors contemplate a tip and a laser porator for porating a biological tissue such as the skin, for example for delivering a high amount of a drug within a small area of for example less than 1 cm2.
It is generally preferred that at least some of the pores have a predetermined geometry that is at least in part a function of the drug. Moreover, the predetermined geometry will preferably control the inner pore surface area, the time to pore re-closure, and/or the pore depth (i.e., layer of epidermis or dermis that is contacted with the drug). The drug (or drugs) is then applied to the area of porated skin, which may be done in single, repeated, or continuous (e.g., under occlusion) manner. While numerous alternative wavelengths are deemed suitable, particularly preferred wavelengths for laser ablation is at a wavelength of at least 2500 nm, and most preferably at about 2950 nm.
The following figures and description will provide sufficient guidance to a person of ordinary skill in the art to make and use the tips contemplated herein.
By way of example only, embodiments of the invention are described with reference to the accompanying drawings, in which:
a and 18b show a plan view of the skin with an array of microporations;
a to 35d show an actively controlled hollow member 10i in different positions.
The tip 8 preferably forms a container with a cylindrical wall 8n and a protective glass 8i. This container collects the ablated tissue and other matter released by the ablation. The tip 8 is preferably shaped so as to allow easy attachment and removal of the tip 8 from the housing 9 of the laser-porator.
The protective glass 8i is an at least partially transparent medium for the laser beam 4 and may be made of glass, polycarbonate, or another medium that is at least partial transparent for the laser beam 4. Instead of the protective glass 8i an optical-path-correction element such as for example a F-Theta lens may be arranged. The use of the optical-path-correction element is advantageous in conjunction with the scanning mirror 8f to create a similar pattern of the laser beam 4 on the skin 1, independent of the deflection of the scanning mirror 8f and independent whether the tissue is cambered to the direction of the laser aperture (like e.g. a toe nail) or it is cambered into the tissue. In a further embodiment a tip 8 comprising an optical-path-correction element as well as a tissue biasing element 8a may be used to ensure the desired shape and position for the laser beam 4 to hit the surface 1a of the skin 1.
The tip 8 comprises a tissue biasing element 8a which biases the portion of skin 1 that is within the opening of the tip 8, which means within the aperture 8x or the optical pathway of the laser beam 4 respectively, into a predetermined shape (e.g., downward, to create a bowl shape) as indicated by the line 1a. Preferably, the tissue biasing element 8a creates a concave shape, in particular a spherical shape, having its center of curvature at point R of the deflecting mirror 8f, wherein Point R is the reflecting point of laser beam 4. Therefore, tissue biasing element 8a will allow laser beam 4 to have about equal length between the deflecting mirror 8f and the surface 1a of the skin 1, which in turn allows creating a highly reproducible geometry of the pores within the skin. Most preferably the tissue biasing element 8a is protruding to the aperture 8x or the optical pathway of the laser beam 4 respectively, as disclosed for example in
The tip 8 may further comprise electrical contact elements 8o, 8q that are electrically coupled to an electrical conductor such as a wire 8p. The contact elements 8q are connected with the contact elements 9a of the laser device 9. This arrangement allows measuring various physiological parameters (e.g., impedance of the skin 1 between the contact elements 8o) of the skin. Most preferably, the contacts may also be used in a locking mechanism to ensure that the tip 8 is properly positioned on the skin, before the laser source is activated. The tip 8 can comprise further sensors, for example, sensors to measure humidity, temperature, or pH of the skin. Because laser beam 4 might cause injuries if not handled properly, it is important that the laser beam 4 is only activated when the tip 8 is placed onto the skin. Thus, as shown in
The tissue biasing element 8a of the tip 8 shown in
It is generally contemplated that the disposable tips 8 as shown in one of the
The tip 8 may further comprise one or more elements 8w to stretch the skin 1, for example, an elastic ring as shown in
It should further be appreciated that various types of connectors (e.g., snap lock or threaded) are suitable to coupled the tip 8 with the housing 9. In one preferred embodiment, the position of the tip 8 with respect to the housing 9 is checked before the laser-porator is directed onto the skin. In another preferred embodiment, the tip 8 comprises an indicator 8g which allows detecting the position of the tip 8 with respect to the housing 9. The indicator 8g can be a reflective surface on the tissue biasing element 8a, which may be arranged on the cross section 8e of the elements 8b as illustrated in
In a preferred embodiment the laser porator 10 also includes a feedback loop 13 respectively a feedback mechanism. In
The porator further can comprise one or more input-output devices or user interfaces 15 for manually exchange date like data of substances, individuals and much more. The user interface can for example comprise displays, buttons, voice control or a finger print sensor.
There are different ways to build a laser source 7. The laser source 7 may, for example, be built as a laser diode with optics that create a beam 4 of fixed width, for example a width of 250 μm.
The pulse repetition frequency of the laser source 7 is within a range of 1 Hz to 1 MHz, preferably within 100 Hz to 100 kHz, and most preferred within 500 Hz to 10 kHz. Within one application of the laser porator 10, between 2 and 1 million individual pores 2 can be produced in the biological membrane 1, preferably 10 to 10000 individual pores 2, and most preferred 10 to 1000 individual pores 2, each pore 2 having a width in the range between 0.05 mm and 0.5 mm or up to 1 mm, and each pore 2 having a depth in the range between 5 μm and 200 μm, but the lower end of the individual pore 2 being preferably within the epidermis 1b. If necessary the porator 10 is also able to create pores of more than 200 μm depth.
The laser porator 10 also comprises an interlock mechanism, so that a laser pulse is emitted only when it is directed onto the skin 1. The feedback loop 13 could for example be used to detect whether the pulse is directed onto the skin 1. Those skilled in the art will appreciate that there are numerous ways to create an interlock mechanism, and all such ways are contemplated. One embodiment is described in
a shows a plan view of the skin having a regular array of individual pores 2 that collectively form a micro-poration. The micro-poration on the biological membrane, after the laser porator 10 has finished porating, is called “initial microporation”. The poration memory 12 preferably contains the initial microporation dataset, which define the initial microporation. The initial microporation dataset comprises any suitable parameters, including: width, depth and shape of each pore, total number of individual pores 2, geometrical arrangement of the pores 2 on the biological membrane, minimal distance between the pores 2, and so forth. The laser porator 10 creates the pores 2 as defined by the initial microporation dataset. This also allows arranging the individual pores 2 in various shapes on the skin 1, as for example disclosed with
The tissue biasing element 8a may also have a concave shape, as disclosed in
In a preferred embodiment the laser porator 10 comprises sensors 11b or communication means 11b to detect or read at least one of position, shape, type and use of the tip 8 and/or the tissue biasing element 8a. In a preferred embodiment the laser porator 10 comprises a memory 12 to store data of the geometry of the tissue biasing element 8a, in particular the position of the bars 8ab. Preferably the laser porator 10 comprises a control device 11 that deflects by controlling deflector 8f the laser beam based on characteristics of the of the tissue biasing element 8a, in particular to avoid that the laser beam 4 hits the tissue biasing element 8a. In a preferred mode of operation the control device 11 deflects the laser beam 4 by controlling the position of the mirror 8f and by triggering the laser beam 4 in such a way that no laser beam 4 hits the tissue biasing element 8a.
In a simpler embodiment, the laser porator 10 doesn't consider the position of the tissue biasing element 8a, and in particular the bars 8ab, leading to the effect that the laser beam 4 may hit the tissue biasing element 8a, which causes that disadvantage the no pore will be created in the biological tissue 1 on this specific position. This is of no disadvantage if the exact total number and/or shape of the created pores 2 is not of importance.
To keep ablated material within tip 8, it might also be advantageous that the tip 8 comprises a tissue biasing element 8a with a plurality of apertures 8x, though which the laser beam 4 passes to hit the underlying tissue 1. The apertures 8x support to keep the ablated material within the first cavity.
The optical path correction element 8i may be part of the tip 8, but most preferably the optical path correction element 8i is part of the laser porator 10, so the same optical path correction element 8i can be used many times.
a to 35d show an actively controlled hollow member 10i in different positions, the hollow member 10i being preferably arranged within the housing 9 of the ablator 10 and being connected by line 10e with the aperture 8j of tip 8. Before using the ablator 10, a motor 10m comprising a shaft 10l compresses a spring 10n, whereby the hollow member 10i is connected to the spring On such that the volume of the hollow member 10i decreases, as disclosed in
Thus, specific embodiments and applications of tips for a laser emitting device for porating of biological tissue or skin have been disclosed. It should be apparent, however, to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the spirit of the present disclosure. Moreover, in interpreting the specification and contemplated claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. Furthermore, where a definition or use of a term in a reference, which is incorporated by reference herein, is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
It should be especially appreciated that the tip 8 described herein is configured to be used in combination with a laser porator. Therefore, it should be recognized that such tips may not only be used for treating skin related conditions but may also be used independently in applications where microporation, and particularly microporation with predetermined pore geometry or drug delivery kinetic/dynamic is required. For example, contemplated alternative uses include application of the tip to create pores for systemic, transdermal administration of permeants and drugs, such as the administration of high amount of drugs, and also the transdermal administration through an area of equal or less than 1 cm2.
Number | Date | Country | Kind |
---|---|---|---|
PCT/EP2006/067772 | Oct 2006 | EP | regional |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP07/61502 | 10/25/2007 | WO | 00 | 4/23/2009 |